NasdaqGS - Nasdaq Real Time Price USD

XBiotech Inc. (XBIT)

2.9800
+0.0700
+(2.41%)
At close: May 13 at 4:00:01 PM EDT
2.9800
0.00
(0.00%)
After hours: May 13 at 4:05:08 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
4,010
18,394
Cost of Revenue
1,681
--
0
651
5,820
Gross Profit
6,529
--
0
3,359
12,574
Operating Expense
42,471
42,471
37,510
37,849
37,656
Operating Income
-42,471
-42,471
-37,510
-34,490
-25,082
Net Non Operating Interest Income Expense
9,005
9,005
10,421
3,823
467
Other Income Expense
-5,097
-5,097
2,776
-2,921
-843
Pretax Income
-38,563
-38,563
-24,313
-33,588
-25,458
Tax Provision
-32
-32
244
-688
-8,044
Net Income Common Stockholders
-38,531
-38,531
-24,557
-32,900
-17,414
Diluted NI Available to Com Stockholders
-38,531
-38,531
-24,557
-32,900
-17,414
Basic EPS
-1.26
-1.26
-0.81
-1.08
-0.58
Diluted EPS
-1.26
-1.26
-0.81
-1.08
-0.58
Basic Average Shares
30,460.9800
30,460.9800
30,438.4590
30,439.2750
30,043.3800
Diluted Average Shares
30,460.9800
30,460.9800
30,438.4590
30,439.2750
30,043.3800
Total Operating Income as Reported
-42,471
-42,471
-37,510
-34,490
-25,082
Total Expenses
42,471
42,471
37,510
38,500
43,476
Net Income from Continuing & Discontinued Operation
-38,531
-38,531
-24,557
-32,900
-17,414
Normalized Income
-33,006.5880
-33,006.5880
-26,052.4700
-30,156
-16,927.6760
Interest Income
9,812
9,812
10,421
3,823
467
Interest Expense
807
807
0
--
--
Net Interest Income
9,005
9,005
10,421
3,823
467
EBIT
-37,756
-37,756
-24,313
-34,490
-25,082
EBITDA
-36,011
-36,011
-22,569
-31,876
-22,434
Reconciled Cost of Revenue
1,681
--
0
651
5,820
Reconciled Depreciation
1,745
1,745
1,744
2,614
2,648
Net Income from Continuing Operation Net Minority Interest
-38,531
-38,531
-24,557
-32,900
-17,414
Total Unusual Items Excluding Goodwill
-5,529
-5,529
1,893
-2,800
-711
Total Unusual Items
-5,529
-5,529
1,893
-2,800
-711
Normalized EBITDA
-30,482
-30,482
-24,462
-29,076
-21,723
Tax Rate for Calcs
0
0
0.0002
0
0.0003
Tax Effect of Unusual Items
-4.5880
-4.5880
397.5300
-56
-224.6760
12/31/2021 - 4/15/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XLS.SW Xlife Sciences AG
20.00
-4.76%
 
GOVXW GeoVax Labs, Inc.
0.0312
-30.67%
 
TSBX Turnstone Biologics Corp.
0.3400
+1.77%
 
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
 
NXTC NextCure, Inc.
0.4485
+3.27%
 
ALXO ALX Oncology Holdings Inc.
0.4810
+10.52%
 
PLRX Pliant Therapeutics, Inc.
1.3800
-6.12%
 
SANN.SW Santhera Pharmaceuticals Holding AG
13.26
-1.19%
 
ACRV Acrivon Therapeutics, Inc.
1.1300
-5.83%
 
KPRX Kiora Pharmaceuticals, Inc.
3.1933
-0.83%